1.44
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AzurRx BioPharma Inc | AZRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 1.44 | 05:19:18 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.44 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.45 | 1.49 | 0.04 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 15 | 2,474 | 12,151,250 | 0.370868 - 2.63 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 05:36:37 | 7 | $ 1.52 | USD |
AzurRx BioPharma Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 49.46M | 34.35M | 33.36M | $ - | $ - | -0.70 | -2.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
AzurRx BioPharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AZRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.67 | 1.7296 | 1.2536 | 1.55 | 2,147,712 | -0.23 | -13.77% |
| 1 Month | 1.54 | 2.05 | 1.2536 | 1.67 | 4,203,611 | -0.10 | -6.49% |
| 3 Months | 0.7711 | 2.63 | 0.7301 | 1.58 | 8,270,103 | 0.6689 | 86.75% |
| 6 Months | 0.7897 | 2.63 | 0.6501 | 1.56 | 3,860,644 | 0.6503 | 82.35% |
| 1 Year | 0.8268 | 2.63 | 0.370868 | 1.51 | 2,061,538 | 0.6132 | 74.17% |
| 3 Years | 2.62 | 3.75 | 0.370868 | 1.49 | 817,843 | -1.18 | -45.04% |
| 5 Years | 5.06 | 5.60 | 0.370868 | 1.54 | 573,370 | -3.62 | -71.54% |
AzurRx BioPharma Description
| AzurRx BioPharma Inc is a development stage biopharmaceutical company. The company is focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome-related conditions. Its lead product candidate is MS1819, a yeast-derived recombinant lipase for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis (CF) and chronic pancreatitis (CP). |
